These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3306530)

  • 1. [Perspectives in the use of monoclonal antibodies in the therapy of neoplastic diseases].
    Emmrich F
    Onkologie; 1987 Jun; 10(3):121-4. PubMed ID: 3306530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective stimulation of human T lymphocyte subsets by heteroconjugates of antibodies to the T cell receptor and to subset-specific differentiation antigens.
    Emmrich F; Rieber P; Kurrle R; Eichmann K
    Eur J Immunol; 1988 Apr; 18(4):645-8. PubMed ID: 3259189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
    Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
    Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity.
    Ozaki S; Berzofsky JA
    J Immunol; 1987 Jun; 138(12):4133-42. PubMed ID: 2438335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell activation by cross-linking anti-CD3 antibodies with second anti-T cell antibodies: dual antibody cross-linking mimics physical monocyte interaction.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Nov; 17(11):1611-8. PubMed ID: 2960544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.
    Janeway CA; Haque S; Smith LA; Saizawa K
    J Mol Cell Immunol; 1987; 3(2):121-31. PubMed ID: 2978238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
    Merćep M; Bluestone JA; Noguchi PD; Ashwell JD
    J Immunol; 1988 Jan; 140(1):324-35. PubMed ID: 2891766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
    Anderson P; Nagler-Anderson C; O'Brien C; Levine H; Watkins S; Slayter HS; Blue ML; Schlossman SF
    J Immunol; 1990 Jan; 144(2):574-82. PubMed ID: 2104899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for monoclonal antibody therapy of leukemia and lymphoma.
    Badger CC; Bernstein ID
    Cancer; 1986 Jul; 58(2 Suppl):584-9. PubMed ID: 3521840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
    Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
    J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Tumor Antigens and Cancer Immunotherapy.
    Vigneron N
    Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered monoclonal antibodies armed with radionuclides.
    Waldmann TA
    Year Immunol; 1993; 7():205-12. PubMed ID: 8103951
    [No Abstract]   [Full Text] [Related]  

  • 15. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
    Bamezai A; Goldmacher V; Reiser H; Rock KL
    J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.
    van Lier RA; Borst J; Vroom TM; Klein H; Van Mourik P; Zeijlemaker WP; Melief CJ
    J Immunol; 1987 Sep; 139(5):1589-96. PubMed ID: 2442250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of alloreactive cytolytic T lymphocytes by immobilized anti-CD3 monoclonal antibodies. Analysis of requirements for human cytolytic T-lymphocyte differentiation.
    De Jong R; Brouwer M; Rebel VI; Van Seventer GA; Miedema F; Van Lier RA
    Immunology; 1990 Jul; 70(3):357-64. PubMed ID: 2143171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology. Considering therapeutic antibodies.
    Vitetta ES; Ghetie VF
    Science; 2006 Jul; 313(5785):308-9. PubMed ID: 16857927
    [No Abstract]   [Full Text] [Related]  

  • 20. Adoptive T-cell immunotherapy of cancer.
    Li Q; Chang AE
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):105-17. PubMed ID: 10515683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.